Sells itself? So you think that this will require nothing more than occasionally beaming a grinning CEO via Zoom into the top oncology units in Europe and they’ll lap it up? IMHO I wouldn’t underestimate the challenges of selling this. And I really must disagree, (though I agree this device has some potential), the idea patients have little else isn’t correct. It’s a message OSL understandably would like everybody to believe but is about as credible as a scientific pronouncement from D Trump. Chemo has got better and radiation therapy techniques are improving all the time in this disease....evidence with focused stereotactic RT is looking promising. This is easily fact- checked. It’s a tough disease but Yes patients have other options.
OSL Price at posting:
11.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)